Delivery Order SPE2DB24D2003-SPE2DB24FXEV2
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of VARIVAX vaccine with diluents. The firm-fixed-price Delivery Order, valued at $2,064.22, has an ultimate completion date of April 29, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,911.94 firm-fixed-price delivery order is for the provision of VARIVAX vaccine with diluents. The contract has an ultimate completion date of July 3, 2024. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,370.10 Firm Fixed Price Delivery Order is for the supply of VARIVAX vaccine with diluents. The contract has an ultimate completion date of July 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award, valued at $9,304.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of VARIVAX vaccine with diluents, with a period of performance through May 15, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,064.22 and running through April 2025. The contract is for the supply of VARIVAX vaccine with diluents, a critical medical commodity used for infectious disease prevention. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA). The contract, valued at $7,443.28, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. As the prime contractor, Amerisourcebergen leverages its expertise in...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (DO) contract under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $2,811.03 fixed-price contract is for the delivery of the VARIVAX vaccine with diluents, with a performance period through November 14, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,032.11 firm fixed price delivery order is for the supply of VARIVAX vaccine with diluents. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award, valued at $5,735.82, is for the delivery of VARIVAX vaccine with diluents. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
- This federal contract award was made by the Department of Defense (DoD) Medical Supply Chain agency to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,867.91 firm fixed-price delivery order is for the supply of VARIVAX vaccine with diluents, with a performance period running through June 12, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the Defense Logistics Agency (DLA) Troop...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB24FXEV2Delivery Order
This federal contract award, valued at $2,811.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of VARIVAX vaccine with diluents, a critical medical product used by the Department of Defense (DoD) and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. This specific order is not set-aside and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 6/3/24 |